Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.9600
-0.0400 (-4.00%)
May 6, 2025, 4:00 PM EDT - Market closed
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $4.93 million as of May 6, 2025. Its market cap has increased by 27.54% in one year.
Market Cap
4.93M
Enterprise Value
-940.53K
1-Year Change
27.54%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $4.93M, a decrease of -81.17%. That is a compound annual growth rate of -36.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2025 | 4.93M | -11.94% |
| Dec 31, 2024 | 5.60M | 17.66% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |